search
Aptadir Therapeutics
Trends
- 1CE-Ventures Backs Aptadir Therapeutics in €40 Million Seed Round●CE-Ventures Backs Aptadir Therapeutics in €40 Million Seed Round, One of Europe’s Largest in Biotech
CE-Ventures has led a €40 million seed round for Aptadir Therapeutics, described as one of the largest seed investments in European biotech. The funding will support the early-stage therapeutics company as it advances its pipeline. The size of the round at seed stage stands out in a market where biotech funding has become more selective, drawing attention from investors and industry watchers.
- 2Italian biotech Aptadir raises €40M seed round for RNA inhibitors●Italian newco Aptadir raises €40M seed round for RNA inhibitors
Aptadir, a newly formed Italian biotech company, has raised a €40 million seed round to develop RNA inhibitors. The funding marks one of the larger seed rounds for an Italian life sciences startup and will support early-stage development of the company's RNA-targeting therapeutic platform as it builds out its research operations.
- 3Milan biotech Aptadir Therapeutics raises $45 million seed round●Milan-based biotech Aptadir Therapeutics raises $45M seed round
Aptadir Therapeutics, a biotech startup based in Milan, has raised a $45 million seed funding round, one of the larger early-stage raises in the European biotech sector. The funding gives the young company substantial resources to advance its research and development programs, and highlights growing investor appetite for Italian and European life sciences ventures.